Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGI-003 (arverapamil) for irritable bowel syndrome with diarrhea
2007-003553-82Phase 3Completed
- Sponsor
- AGI Therapeutics plc
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Arverapamil with Placebo (2 arms). Started Aug 2007; status: completed.
02
Drugs
dexverapamil
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on 2007-003553-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003553-82.